IRVINE: Sabra Health Care REIT announced that Fitch Ratings has affirmed the ratings for Sabra and its subsidiaries at ‘BBB-‘; Fitch’s Rating Outlook of Negative also remains unchanged. The report notes Sabra’s portfolio quality and diversification, strong liquidity and no near-term maturities as key drivers for its ratings decisions. Fitch also views Sabra’s recent decision…